Keith Tan

Keith Tan is a retired professional who concluded a 30-year career in the pharmaceutical industry, specializing in translational medicine and clinical pharmacology. Most recently, they served as the VP and Head of Translational Medicine, Neuroscience, Biopharmaceutical R&D at AstraZeneca. Their previous experience includes significant leadership roles at Pfizer and MedImmune, where they contributed to successful regulatory submissions and the development of new therapies. Keith holds a PhD in Clinical Pharmacology from the University of Cambridge, along with an MSc from the University of Aberdeen and a BPharm from the University of Bath.